Titlebook: Drug-Coated Balloons; Applications in Inte Bernardo Cortese Book 2019 Springer Nature Switzerland AG 2019 drug-eluting balloon.angioplasty

Interferons

執(zhí)拗

The Use of Drug-Coated Balloons for Patients with In-Stent Restenosis,estenosis (ISR) [1]. Other scenarios for the use of DCB include small vessels, diffuse disease, and coronary bifurcation where the systematic implantation of a stent is not very attractive or is associated with adverse clinical and angiographic results. Information on the value of DCB in these setti

性滿足

Drug-Coated Balloons in Native Coronary Artery Disease,estenosis caused byneointimal hyperplasia. Some of the limitations of DES include treatment of small vessel disease, issues related to the duration of dual antiplatelet therapy (DAPT), and treatment failure leading to restenosis and late or very late stent thrombosis, especially in complex lesions s

有權(quán)

Drug-Eluting Balloons in Coronary Bifurcation Lesions,il and late negative remodeling and by pharmacologically inhibiting neointimal hyperplasia [1]. However complex lesions, such as bifurcation lesions, which account for 15–20% of all lesions treated percutaneously [2], remain hampered by technical difficulties, periprocedural complications, and subop